Skip to main content
Premium Trial:

Request an Annual Quote

Timothy Stout, Mark Caulfield, Tim Aitman, Alan Ashworth, Aroon Hingorani, Ellen Solomon, Brendan Wren, Nick Carter, Shirley Hodgson, Nina Fedoroff, Richard Zakour

Premium
Oregon Health and Science University said last week that Timothy Stout has been appointed to the newly created position of vice president for commercialization strategies, effective Sept. 1.
 
Stout is currently an associate professor of ophthalmology at the OHSU Casey Eye Institute. Stout holds a PhD in molecular genetics and MD from Baylor College of Medicine. He completed an internship in general pediatrics at Houston’s Texas Children’s Hospital, and was a fellow in human genetics at Baylor. He completed his ophthalmology residency at Doheny Eye Hopsital at the University of Southern California, and a retina fellowship at Moorfields Eye Hopsital in London. He also holds an MBA from the Oregon Executive MBA program.
 
OHSU said that Stout will report to OHSU executive vice president Steve Stadum, and will work closely with Daniel Dorsa, OHSU’s vice president for research, and with the Office of Technology and Research Collaborations, headed by Arundeep Pradhan.
 

 
London Genetics, a company that facilitates and manages partnerships between the healthcare industry and London-based centers of excellence in genomics-based medical research, last week announced the formation of its scientific advisory board.
 
The board will be chaired by Mark Caulfield, professor of clinical pharmacology at Queen Mary, University of London. The board will also include:
  • Tim Aitman, professor of clinical and molecular genetics, Imperial College London
  • Alan Ashworth, director, Breakthrough Breast Cancer Research Center, Institute of Cancer Research
  • Aroon Hingorani, British Heart Foundation senior research fellow, division of medicine, University College, London
  • Ellen Solomon, head, medical and molecular genetics, King’s College London
  • Brendan Wren, head of pathogen molecular biology, London School of Hygiene and Tropical Medicine
  • Nick Carter, head of clinical developmental sciences, St. George’s, University of London
  • Shirley Hodgson, professor, cancer genetics, St. George’s, University of London

 
Nina Fedoroff, a former Sigma-Aldrich director and Penn State University professor, has been named science and technology adviser to US Secretary of State Condoleezza Rice.
 
Fedoroff was nominated for the post by the National Academy of Sciences. She resigned from her spot on Sigma-Aldrich’s board, but remains chair of the life sciences and an Evan Pugh professor at Penn State.
 

 
The Tech Council of Maryland has tapped Richard Zakour to be executive director of MdBio and the MdBio Foundation.
 
Zakour was formerly general manager of Fisher BioSciences and previously was in management at McKesson Clinical Consulting Services, DynCorp, and Cambridge Biotech. Zakour was a member of TCM’s board of directors between 2003 until early 2007 and he served on MdBio Foundation’s board as well.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.